2020 Year In Review: Rising to New Challenges | InSphero

2020 Year In Review: Rising to New Challenges

Blog | 3D Cell-based technology

Shipping Live Mini-Organs Around the World
November 26, 2020
Measuring Aspartate Transaminase (AST) In Vitro – Closing the Gap to Clinical Data
April 16, 2021

2020 Year In Review: Rising to New Challenges

InSphero CEO Jan Lichtenberg extends holiday greetings from our teams in Switzerland and the United States, and looks back on the highlights of 2020: a tumultuous year shaped by a global pandemic.

 

Season's Greetings from InSphero

Dear friends and partners of InSphero,

A remarkable year 2020 draws to an end. The pandemic came like a thief at night. It showed us how vulnerable our modern society still is – and how much more we need to learn in the field of life science.

Our team at InSphero looks back at a challenging year which we successfully navigated together. Despite the pandemic restrictions InSphero continues to grow and we moved into a larger, new office and laboratory space this summer. Our 3D Discovery Platforms in diabetes, NASH, liver steatosis and oncology generated exciting results for our pharma and biotech partners, have helped to identify new compounds or to understand the mechanism of action of existing ones. Our drug-safety programs continue to help our partners to address hazards early on and to save time to market in the clinical phase. Very exciting for us, we have started out-licensing activities for InSphero’s first own pharmaceutical assets.

Personally, I miss the opportunities to get together with you all, whether it is at scientific conferences, at business meetings or for a private dinner. I keep my fingers crossed that we will have the chance to do this in 2021.

Thank you for the many collaborations with us this year and our best wishes for a successful and healthy new year 2021!

Jan Lichtenberg, PhD
InSphero CEO and Co-founder

 

 

Jan

Jan

Dr. Jan Lichtenberg is CEO and Co-founder of InSphero AG. An engineer and expert in laboratory automation with 20 years of experience in the life sciences, Jan earned his PhD in Microtechnology and Microfluidics at the University of Neuchâtel .

Leave a Reply

Your email address will not be published. Required fields are marked *

Meet the Author

Jan

Jan

Dr. Jan Lichtenberg is CEO and Co-founder of InSphero AG. An engineer and expert in laboratory automation with 20 years of experience in the life sciences, Jan earned his PhD in Microtechnology and Microfluidics at the University of Neuchâtel .

Spread the Knowledge

Read our newsletter for the latest news about
3D InSight™ platforms for discovery and safety testing